ArticleBMC cancer2021
High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer.
Takuya Shiraishi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it